UBI.PA stock: Ubisoft Entertainment SA (EURONEXT) down 7.75% 12 Feb 2026: model view

UBI.PA stock fell 7.75% at market close on 12 Feb 2026, ending the session at €4.30 after a volatile day on EURONEXT. The decline adds to a year-to-date slump of -34.31% as investors digest recent restructuring, multiple game cancellations and weaker bookings. Trading volume accelerated to 1,798,542 shares, above the average of 1,233,411, signalling active selling. We examine the drivers behind today’s drop, how balance-sheet metrics such as EPS -0.54 and debt/equity 1.34 connect to price action, and what Meyka AI’s model projects next

Price action and immediate drivers

One claim: UBI.PA stock closed at €4.30, down €0.36 or 7.75%, with a daily range of €4.08–€4.33. Trading volume was 1,798,542, a relVolume of 1.39, showing heavier-than-normal turnover. One claim: Sellers cited the company’s recent cancellations and sweeping restructure, which previously triggered a 33% single-day plunge. One claim: Market reaction reflects both headline risk and reduced near-term revenue visibility tied to postponed titles.

Fundamentals: cash, debt and profitability

One claim: Ubisoft (UBI.PA) reports market cap €561,921,291, EPS -0.54, and PE -7.72, highlighting negative earnings but significant asset backing with book value per share €11.94. One claim: Key leverage ratios matter—debt/equity 1.34 and netDebt/EBITDA 3.09 increase sensitivity if sales slow. One claim: Positive cash metrics—cash per share €5.10, operating cash flow per share €6.25 and free cash flow per share €5.95—provide a partial buffer for restructuring costs.

Technical picture and short-term setup for UBI.PA stock

One claim: Technicals show limited momentum; RSI 40.75 and ADX 13.79 indicate no strong trend. One claim: Price sits well below the 50-day average €5.75 and 200-day average €8.17, leaving scope for mean reversion only if sentiment stabilises. One claim: Oscillators (Stochastic %K 29.33) lean toward oversold territory, but volume indicators (OBV -6,048,636) confirm distribution.

Sector context and comparative valuation

One claim: Ubisoft sits in Europe’s Technology sector, where the average PE is 32.84; UBI.PA’s negative PE contrasts sharply with peers. One claim: Valuation multiples show a low price-to-sales 0.30 and price-to-book 0.35, implying the market values Ubisoft more on asset and IP recovery potential than current earnings. One claim: Sector performance is mixed, and game publishers face higher cyclical risk than software infrastructure peers.

Recent news links to price moves

One claim: Management’s cancellation of six titles and studio closures remains the dominant headline driving selling pressure; coverage showed the company cut guidance and reorganised into five creative divisions. One claim: Investors also reacted to bookings volatility tied to flagship franchises. See coverage for context: Investing.com report and a revenue summary at StockAnalysis.

Meyka AI rating, technical view and analyst frame

One claim: Meyka AI rates UBI.PA with a score out of 100: Score 69.36 | Grade B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. One claim: Technical indicators and free cash flow metrics support a cautious hold stance, while the company’s restructure keeps downside risk elevated. One claim: These grades are not guaranteed and we are not financial advisors.

Final Thoughts

Key takeaways: UBI.PA stock closed at €4.30 on 12 Feb 2026 after a 7.75% decline as investors weighed the impact of cancelled projects, studio closures and reduced near-term visibility. Balance-sheet strengths — cash per share €5.10 and solid free cash flow per share €5.95 — partly offset leverage concerns (debt/equity 1.34 and netDebt/EBITDA 3.09). Meyka AI’s forecast model projects a monthly target €4.84 (implied upside 12.56% vs current price) and a quarterly target €8.11 (implied upside 88.60%). Forecasts are model-based projections and not guarantees. Given the mix of headline risk, low trading multiples (P/S 0.30, P/B 0.35) and restructuring uncertainty, we view the stock as a tactical HOLD for patient investors, while shorter-term traders should monitor bookings and pipeline updates closely. For the latest price and model updates, see our UBI.PA stock page on Meyka and referenced news sources above

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.